Results 41 to 50 of about 77,059 (283)

The relationship of the factor V Leiden mutation or the deletion-deletion polymorphism of the angiotensin converting enzyme to postoperative thromboembolic events following total joint arthroplasty [PDF]

open access: yes, 2001
Background Although all patients undergoing total joint arthroplasty are subjected to similar risk factors that predispose to thromboembolism, only a subset of patients develop this complication.
Craig J Della Valle   +29 more
core   +2 more sources

Current perspective of venous thrombosis in the upper\ud extremity [PDF]

open access: yes, 2008
Venous thrombosis of the upper extremity is a rare disease. Therefore, not as much is known about risk factors, treatment and the risk of recurrence as for venous thrombosis of the leg.
Doggen, C.J.M.   +3 more
core   +3 more sources

Evaluation the frequency of factor V Leiden mutation in pregnant women with preeclampsia syndrome in an Iranian population [PDF]

open access: yesIranian Journal of Reproductive Medicine, 2012
Background: Role of genetic factors in etiology of preeclampsia is not confirmed yet.Objective: Gene defect frequency varies in different geographic areas as well as ethnic groups.
Azadeh Azinfar   +4 more
doaj  

Factor V Leiden mutation: An added risk in single ventricle palliation

open access: yesAnnals of Pediatric Cardiology, 2012
We present the case report of a child with Factor V Leiden mutation who underwent Fontan procedure. Thromboembolism is a widely recognized complication of the Fontan procedure and its modifications. Factor V Leiden mutation, being a hypercoagulable state,
R Saileela   +4 more
doaj   +1 more source

Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: Results of a 25-year follow-up study [PDF]

open access: yes, 2003
AIM: IBD is a systemic disease associated with a large number of extraintestinal manifestations (EIMs). Our aim was to determine the prevalence of EIMs in a large IBD cohort in Veszprem Province in a 25-year follow-up study.
Balogh, Zsuzsanna   +6 more
core   +1 more source

The GOAL study: a prospective examination of the impact of factor V Leiden and ABO(H) blood groups on haemorrhagic and thrombotic pregnancy outcomes [PDF]

open access: yes, 2008
Factor V Leiden (FVL) and ABO(H) blood groups are the common influences on haemostasis and retrospective studies have linked FVL with pregnancy complications. However, only one sizeable prospective examination has taken place.
Carstairs V.   +17 more
core   +1 more source

Study of some genetic predisposition in pulmonary embolism

open access: yesEgyptian Journal of Chest Disease and Tuberculosis, 2014
Background: There is increasing recognition of genetic deficiencies underlying pulmonary embolism in some individuals, particularly those with early onset of disease, unusual sites of venous thrombosis and recurrent disease.
Gehan Elassal   +2 more
doaj   +1 more source

Research Models for Studying Vascular Calcification [PDF]

open access: yes, 2020
Calcification of the vessel wall contributes to high cardiovascular morbidity and mortality. Vascular calcification (VC) is a systemic disease with multifaceted contributing and inhibiting factors in an actively regulated process.
Babic, Milen   +4 more
core   +1 more source

Factor V Leiden Mutation–Related Chronic Skin Ulcers

open access: yesThe International Journal of Lower Extremity Wounds, 2013
Chronic skin ulcers require extensive, systemic differential diagnosis; thus, they are difficult to diagnose and treat. Transient or persistent hypercoagulable states are among the rare causes of skin ulcers. Here, we present the case of a 27-year-old woman patient with recurrent, nonhealing skin ulcers of 8 years’ duration, who had been treated ...
Karatoprak, CUMALİ   +5 more
openaire   +3 more sources

Neuid: A Novel Neuron‐Enriched LncRNA that Connects Epigenetic Gene Silencing to Alzheimer's Disease

open access: yesAdvanced Science, EarlyView.
ABSTRACT The increasing evidence that non‐coding RNAs can become deregulated during pathogenesis is dramatically expanding the space for drug discovery beyond the protein‐coding genome. Long noncoding RNAs (lncRNAs) are emerging as key regulators of cellular function, yet most remain uncharacterized.
Ranjit Pradhan   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy